These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7585567

  • 1. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
    Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, Balmain A.
    Cancer Res; 1995 Nov 15; 55(22):5168-72. PubMed ID: 7585567
    [Abstract] [Full Text] [Related]

  • 2. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 3. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
    Herzog CR, Soloff EV, McDoniels AL, Tyson FL, Malkinson AM, Haugen-Strano A, Wiseman RW, Anderson MW, You M.
    Oncogene; 1996 Nov 07; 13(9):1885-91. PubMed ID: 8934534
    [Abstract] [Full Text] [Related]

  • 4. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
    Malumbres M, Pérez de Castro I, Santos J, Meléndez B, Mangues R, Serrano M, Pellicer A, Fernández-Piqueras J.
    Oncogene; 1997 Mar 20; 14(11):1361-70. PubMed ID: 9178896
    [Abstract] [Full Text] [Related]

  • 6. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ, Malandro J, Compitello N, Baylin SB, Graff JR.
    Cell Growth Differ; 1999 Jan 20; 10(1):27-33. PubMed ID: 9950215
    [Abstract] [Full Text] [Related]

  • 7. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
    Kim JW, Namkoong SE, Ryu SW, Kim HS, Shin JW, Lee JM, Kim DH, Kim IK.
    Gynecol Oncol; 1998 Jul 20; 70(1):75-9. PubMed ID: 9698478
    [Abstract] [Full Text] [Related]

  • 8. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW.
    Cancer Res; 1996 Nov 01; 56(21):5023-32. PubMed ID: 8895759
    [Abstract] [Full Text] [Related]

  • 9. Cloning and characterization of murine p16INK4a and p15INK4b genes.
    Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ, Serrano M.
    Oncogene; 1995 Aug 17; 11(4):635-45. PubMed ID: 7651726
    [Abstract] [Full Text] [Related]

  • 10. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
    Zariwala M, Liu E, Xiong Y.
    Oncogene; 1996 Jan 18; 12(2):451-5. PubMed ID: 8570224
    [Abstract] [Full Text] [Related]

  • 11. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
    Zindy F, Quelle DE, Roussel MF, Sherr CJ.
    Oncogene; 1997 Jul 10; 15(2):203-11. PubMed ID: 9244355
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS.
    Clin Cancer Res; 1999 Oct 10; 5(10):2704-13. PubMed ID: 10537333
    [Abstract] [Full Text] [Related]

  • 13. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
    Knapek DF, Serrano M, Beach D, Trono D, Walker CL.
    Cancer Res; 1995 Apr 15; 55(8):1607-12. PubMed ID: 7712460
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, Sengoku K, Ishikawa M.
    Exp Cell Res; 1997 Jun 15; 233(2):233-9. PubMed ID: 9194486
    [Abstract] [Full Text] [Related]

  • 15. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T, Mizushima Y, Kashii T, Kobayashi M.
    Anticancer Res; 1998 Jun 15; 18(3A):1537-42. PubMed ID: 9673367
    [Abstract] [Full Text] [Related]

  • 16. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B, Langan TA, Sclafani RA.
    Cell Growth Differ; 2000 Oct 15; 11(10):507-15. PubMed ID: 11063124
    [Abstract] [Full Text] [Related]

  • 17. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
    Güran S, Bahçe M, Beyan C, Korkmaz K, Yalçin A.
    Haematologia (Budap); 1998 Oct 15; 29(3):181-93. PubMed ID: 10069444
    [Abstract] [Full Text] [Related]

  • 18. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.
    Zhuang SM, Schippert A, Haugen-Strano A, Wiseman RW, Söderkvist P.
    Oncogene; 1998 Feb 12; 16(6):803-8. PubMed ID: 9488045
    [Abstract] [Full Text] [Related]

  • 19. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
    Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J, Berns A.
    Nature; 2007 Aug 23; 448(7156):943-6. PubMed ID: 17713536
    [Abstract] [Full Text] [Related]

  • 20. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M.
    Clin Cancer Res; 1999 Jul 23; 5(7):1855-61. PubMed ID: 10430092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.